The authors reply.

Autor: Barbosa-Silva MC; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil., Rocco PRM, Maron-Gutierrez T
Jazyk: angličtina
Zdroj: Critical care medicine [Crit Care Med] 2020 Jul; Vol. 48 (7), pp. e634-e635.
DOI: 10.1097/CCM.0000000000004391
Databáze: MEDLINE